Yadav, V., Bourdette, D. N., Bowen, J. D., Lynch, S. G., Mattson, D., Preiningerova, J., . . . Vandenbark, A. A. (2012). Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study. Hindawi Publishing Corporation.
Citação norma ChicagoYadav, Vijayshree, et al. Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study. Hindawi Publishing Corporation, 2012.
Citação norma MLAYadav, Vijayshree, et al. Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study. Hindawi Publishing Corporation, 2012.